Picture of Cytek Biosciences logo

CTKB — Cytek Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Cytek Biosciences, Inc. reports results for the quarter ended September 30 - Earnings Summary

Cytek Biosciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
  • Cytek Biosciences, Inc. CTKB.OQ reported a quarterly adjusted loss of 5 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -4 cents. The mean expectation of three analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -8 cents to -6 cents per share.

  • Revenue rose 1.8% to $53.23 million from a year ago; analysts expected $52.80 million.

  • Cytek Biosciences, Inc.'s reported EPS for the quarter was a loss of 5 cents​.

  • The company reported a quarterly loss of $6.1 million.

  • Cytek Biosciences, Inc. shares had held steady so far this quarter and gained 18.0% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 16.7% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

  • Wall Street's median 12-month price target for Cytek Biosciences, Inc. is $5.00, about 19.2% below its last closing price of $5.96

This summary was machine generated from LSEG data November 4 at 10:49 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

-0.07

-0.05

Beat

Jun. 30 2026

-0.08

-0.08

Met

Mar. 31 2026

-0.10

-0.15

Missed

Dec. 31 2025

-0.02

-0.04

Missed

Recent news on Cytek Biosciences

See all news